The patients were tentatively classified into two groups according to the status of PD‐L1 TPS, that is, increased and decreased/unchanged TPS in lymph node metastasis compared to primary cancer lesions. The gene discussed is CD274; the disease is metastatic malignant neoplasm in the lymph nodes.